Elizabeth Liow

First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium

Shaan Dudani, Jeffrey Graham, J. Connor Wells et al. · European Urology · 2019 · 86 citations · Full text

Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial

Edmond M. Kwan, Lavinia Spain, A. Antón et al. · European Urology · 2021 · 65 citations

Ice-pac Clinical Trial, Surgical Oncology, Urology +6

Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort

Michael Fernando, A. Antón, Andrew Weickhardt et al. · Journal of Geriatric Oncology · 2023 · 16 citations

Urology, Health Policy, Geriatrics +8

Pembrolizumab with chemoradiotherapy as treatment for muscle invasive bladder cancer: A planned interim analysis of safety and efficacy of the PCR-MIB phase II clinical trial (ANZUP 1502).

Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk et al. · Journal of Clinical Oncology · 2020 · 15 citations

Surgical Oncology, Anzup 1502, Pharmacotherapy +16

⁸⁹ Zirconium-labelled girentuximab ( ⁸⁹ Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma

Mohammed Al‐Zubaidi, Pravin Viswambaram, Steve P. McCombie et al. · BMJ Open · 2022 · 15 citations · Full text